Amyloid Fibril Formation and Disaggregation of Fragment 1-29 of Apomyoglobin: Insights into the Effect of pH on Protein Fibrillogenesis

Journal of Molecular Biology

Volumn 367, Issue 5, 2007, Pages 1237-1245

  Picotti, Paola ^a   De Franceschi, Giorgia ^a   Frare, Erica ^a   Spolaore, Barbara ^a   Zambonin, Marcello ^a   Chiti, Fabrizio ^b   de Laureto, Patrizia Polverino ^a   Fontana, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

amyloid; circular dichroism; electron microscopy; protein aggregation; protein fragments

Indexed keywords

AMYLOID; APOMYOGLOBIN; APOMYOGLOBIN[1-29]; PEPTIDE FRAGMENT; PROTEIN SUBUNIT; PROTEINASE; THIOFLAVINE; TRYPSIN; UNCLASSIFIED DRUG;

ACIDIFICATION; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONTROLLED STUDY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

EQUIDAE;

EID: 33947103491     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.01.072     Document Type: Article

References (57)

1. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
2. Rochet J.C., and Lansbury Jr. P.T. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
3. Serpell L.C. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta 1502 (2000) 16-30
4. Horwich A. Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. J. Clin. Invest. 110 (2002) 1221-1232
5. Westermark P. Aspects of human amyloid forms and their fibril polypeptides. FEBS J. 272 (2005) 5942-5949
6. Jahn T.R., and Radford S.E. The yin and yang of protein folding. FEBS J. 272 (2005) 5962-5970
7. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
8. Dobson C.M. Protein folding and misfolding. Nature 426 (2003) 884-890
9. Dobson C.M. Protein aggregation and its consequences for human diseases. Protein Pept. Letters 13 (2006) 219-227
10. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
11. Sunde M., and Blake C.C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Advan. Protein Chem. 50 (1997) 123-159
12. Tycko R. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14 (2004) 96-103
13. Makin O.S., and Serpell L.C. Structures for amyloid fibrils. FEBS J. 272 (2005) 5950-5961
14. Chien P., Weissman J.S., and DePace A.H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73 (2004) 617-656
15. Schmittschmitt J.P., and Scholtz J.M. The role of protein stability, solubility and net charge in amyloid fibril formation. Protein Sci. 12 (2003) 2374-2378
16. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., and Dobson C.M. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl Acad. Sci. USA 99 (2002) 16419-16426
17. Wright P.E., and Dyson H.J. Intrinsically unstructured proteins: reassessing the protein structure-function paradigm. J. Mol. Biol. 293 (1999) 321-331
18. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12 (2002) 54-60
19. Tompa P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27 (2002) 527-533
20. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15 (2005) 35-41
21. Hoyer W., Cherny D., Subramaniam V., and Jovin T.M. Impact of the acidic C-terminal region comprising amino acids 109-140 on α-synuclein aggregation in vitro. Biochemistry 43 (2004) 16233-16242
22. Fernandez C.O., Hoyer W., Zweckstetter M., Jares-Erijman E.A., Subramaniam V., Griesinger C., and Jovin T.M. NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23 (2004) 2039-2046
23. Uversky V.N., Li J., and Fink A.L. Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 276 (2001) 10737-10744
24. Göers J., Uversky V.N., and Fink A.L. Polycation-induced oligomerization and accelerated fibrillation of human α-synuclein in vitro. Protein Sci. 12 (2003) 702-707
25. Uversky V.N., Li J., and Fink A.L. Metal-triggered structural transformation, aggregation and fibrillation of human α-synuclein. J. Biol. Chem. 276 (2001) 44284-44296
26. Lowe R., Poutney D., Jensen P.H., Gai W.P., and Voelker N.H. Calcium(II) selectivity induces α-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci. 13 (2004) 3245-3252
27. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., and Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA 95 (1998) 4224-4228
28. Chiti F., Bucciantini M., Capanni C., Taddei N., Dobson C.M., and Stefani M. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain. Protein Sci. 10 (2001) 2541-2547
29. Kad N.M., Myers S.L., Smith D.P., Smith D.A., Radford S.E., and Thomson N.H. Hierarchical assembly of beta2-microglobulin amyloid in vitro revealed by atomic force microscopy. J. Mol. Biol. 330 (2003) 785-797
30. Modler A.J., Gast K., Lutsch G., and Damaschun G. Assembly of amyloid protofibrils via critical oligomers: a novel pathway of amyloid formation. J. Mol. Biol. 325 (2003) 135-148
31. Frare E., Polverino de Laureto P., Zurdo J., Dobson C.M., and Fontana A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 340 (2004) 1153-1165
32. Frare E., Mossuto M.F., Polverino de Laureto P., Dumoulin M., Dobson C.M., and Fontana A. Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J. Mol. Biol. 361 (2006) 551-561
33. Polverino de Laureto P., Taddei N., Frare E., Capanni C., Costantini S., Zurdo J., et al. Protein aggregation and amyloid formation by an SH3 domain probed by limited proteolysis. J. Mol. Biol. 334 (2003) 129-141
34. Eliezer D., Yao J., Dyson H.J., and Wright P.E. Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding. Nature Struct. Biol. 5 (1998) 148-155
35. Fontana A., Zambonin M., Polverino de Laureto P., De Filippis V., Clementi A., and Scaramella E. Probing the conformational state of apomyoglobin by limited proteolysis. J. Mol. Biol. 266 (1997) 223-230
36. Fontana A., Polverino de Laureto P., De Filippis V., Scaramella E., and Zambonin M. Probing the partly folded states of proteins by limited proteolysis. Fold. Des. 2 (1997) R17-R26
37. Fontana A., Polverino de Laureto P., Spolaore B., Frare E., Picotti P., and Zambonin M. Probing protein structure by limited proteolysis. Acta. Biochim. Pol. 51 (2004) 299-321
38. Woody R.W. Circular dichroism. Methods Enzymol. 246 (1995) 34-71
39. Chow C.C., Chow C., Raghunathan V., Huppert T.J., Kimball E.B., and Cavagnero S. Chain length dependence of apomyoglobin folding: structural evolution from misfolded sheets to native helices. Biochemistry 42 (2003) 7090-7099
40. Le Vine H. Thioflavin T interaction with synthetic Alzheimer's diseases beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
41. Fändrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
42. Fändrich M., Forge V., Buder K., Kittler M., Dobson C.M., and Dickmann S. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc. Natl Acad. Sci. USA 100 (2003) 15463-15468
43. DuBay K.F., Pawar A.P., Chiti F., Zurdo J., Dobson C.M., and Vendruscolo M. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J. Mol. Biol. 341 (2004) 1317-1326
44. Pawar A.P., DuBay K.F., Zurdo J., Chiti F., Vendruscolo M., and Dobson C.M. Prediction of "aggregation prone" and "aggregation susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350 (2005) 379-392
45. Yoon S., and Welsh W.J. Detecting hidden sequence propensity for amyloid formation. Protein Sci. 13 (2004) 2149-2160
46. Fändrich M., and Dobson C.M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21 (2002) 5682-5690
47. Uversky V.N., and Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698 (2004) 131-153
48. 2-microglobulin: insights into the mechanism of fibril formation in vitro. J. Mol. Biol. 325 (2003) 249-257
49. Zurdo J. Polypeptide models to understand misfolding and amyloidogenesis and their relevance in a protein design and therapeutics. Protein Peptide Letters 12 (2005) 171-187
50. Findeis M.A. Peptide inhibitors of the beta-amyloid aggregation. Curr. Top. Med. Chem. 2 (2002) 417-423
51. Lopez de la Paz M., Goldie K., Zurdo J., Lacroix E., Dobson C.M., Hoenger A., and Serrano L. De novo designed peptide-based amyloid fibrils. Proc. Natl Acad. Sci. USA 99 (2002) 16052-16057
52. Pastor M.T., Chopo A., and Lopez de la Paz M. Design of model systems for amyloid formation: lessons for prediction and inhibition. Curr. Opin. Struct. Biol. 15 (2005) 57-63
53. Makin O.S., Atkins E., Sikorski P., Johansson J., and Serpell L.C. Molecular basis for amyloid fibril formation and stability. Proc. Natl Acad. Sci. USA 102 (2005) 315-320
54. Cohen T., Frydman-Marom A., Rechter M., and Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45 (2006) 4727-4735
55. Meersman F., and Dobson C.M. Probing the pressure-temperature stability of amyloid fibrils provides new insights into their molecular properties. Biochim. Biophys. Acta 1764 (2006) 452-460
56. Dautrevaux M., Boulanger Y., Han K., and Biserte G. Covalent structure of horse myoglobin. Eur. J. Biochem. 11 (1969) 267-277
57. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326